Learn more about COVID-19 in Saskatchewan. Daily case numbers and information for businesses and workers.

The Re-Open Saskatchewan plan was released on April 23rd.

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow text box that resembles the link below and can be found in the right hand rail of the page. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

The results of software-based translation do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos, and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Saskatchewan Funds Coronavirus Vaccine Research

Released on March 11, 2020

Innovation Saskatchewan is providing researchers at the University of Saskatchewan with $200,000 to help find a vaccine for COVID-19.

The university’s Vaccine and Infectious Disease Organization-International Vaccine Centre is at the forefront of a global search, having previously worked on vaccines for SARS and the Zika virus.  The Saskatoon lab is one of the few research facilities with regulatory approval to work on the new virus.

“Saskatchewan’s infectious disease researchers are among the best in the world and our government is proud to support their efforts in the development of a vaccine to protect against COVID-19,” Minister Responsible for Innovation Saskatchewan Tina Beaudry-Mellor says.

USask researchers are evaluating the safety and efficiency of potential vaccines and medications to reduce the ability of the virus to multiply.  Both are key requirements for regulatory approval of new medicines.  The team hopes to know within weeks whether an effective vaccine has been developed.  If animal trials prove successful, clinical testing involving humans would take place as soon as possible.

“The Saskatchewan government is committed to providing innovators with the support to achieve results that impact people in our province and around the world,” Beaudry-Mellor said.

Collaborating with the World Health Organization and researchers in several countries, the Saskatoon team received a significant grant earlier this month from Canadian federal funding agencies - part of a $26.7-million rapid research initiative to contain the coronavirus outbreak.

“Support for this research is increasingly important as the disease continues to spread,” Vaccine and Infectious Disease Organization-International Vaccine Centre Director and Chief Executive Officer Dr. Volker Gerdts said.  “This support will help in our worldwide efforts to develop a solution for this disease.”


For more information, contact:

Glen Kirby
Innovation Saskatchewan
Phone: 306-787-6041
Email: glen.kirby@gov.sk.ca
Cell: 306-537-6455

We need your feedback to improve saskatchewan.ca. Help us improve